BioCatalystWatch
ARWRWorkspace / ARWR / OverviewCompany library
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC.

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Website

Price
Market cap
Next catalyst2026ARO-INHBE · Phase 1/2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

ARO-MAPT

Tau (MAPT) × MAPT mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

ARO-MAPT

Tau (MAPT) × MAPT mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

APOC3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

ARO-ALK7

ALK7 (ACVR1C)

PreINDP1P2P3FilingApproved
ARO-INHBE

INHBE

PreINDP1P2P3FilingApproved
Upcoming / outlook

ARO-INHBE

INHBE

PreINDP1P2P3FilingApproved
zodasiran

ANGPTL3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ARO-INHBE

INHBE

PreINDP1P2P3FilingApproved
Upcoming / outlook

ARO-MAPT

Tau (MAPT) × MAPT mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

ARO-MAPT

Tau (MAPT) × MAPT mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

APOC3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

zodasiran

ANGPTL3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ARO-ALK7

ALK7 (ACVR1C)

PreINDP1P2P3FilingApproved

Other pipelines

ARO-MAPT

Tau (MAPT) / MAPT mRNA

PreINDP1P2P3FilingApproved
plozasiran (ARO-APOC3)

APOC3

PreINDP1P2P3FilingApproved
plozasiran (ARO-APOC3)

APOC3

plozasiran (ARO-APOC3)

APOC3

ARO-033

PreINDP1P2P3FilingApproved
zodasiran

ANGPTL3

PreINDP1P2P3FilingApproved

Partner / License out

PNPLA3

PreINDP1P2P3FilingApproved

DMPK

PreINDP1P2P3FilingApproved

AAT gene

PreINDP1P2P3FilingApproved

HSD17B13

PreINDP1P2P3FilingApproved

HBV RNAs

PreINDP1P2P3FilingApproved

Apolipoprotein A

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

C3

PreINDP1P2P3FilingApproved

CFB

PreINDP1P2P3FilingApproved

HBV RNA

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ARWR PR & News

PR & News

ARWR SEC archive